Antibacterial and Immunomodulatory Properties of Acellular Wharton's Jelly Matrix
- PMID: 35203437
- PMCID: PMC8869352
- DOI: 10.3390/biomedicines10020227
Antibacterial and Immunomodulatory Properties of Acellular Wharton's Jelly Matrix
Abstract
Of all biologic matrices, decellularized tissues have emerged as a promising tool in the field of regenerative medicine. Few empirical clinical studies have shown that Wharton's jelly (WJ) of the human umbilical cord promotes wound closure and reduces wound-related infections. In this scope, we herein investigated whether decellularized (DC)-WJ could be used as an engineered biomaterial. In comparison with devitalized (DV)-WJ, our results showed an inherent effect of DC-WJ on Gram positive (S. aureus and S. epidermidis) and Gram negative (E. coli and P. aeruginosa) growth and adhesion. Although DC-WJ activated the neutrophils and monocytes in a comparable magnitude to DV-WJ, macrophages modulated their phenotypes and polarization states from the resting M0 phenotype to the hybrid M1/M2 phenotype in the presence of DC-WJ. M1 phenotype was predominant in the presence of DV-WJ. Finally, the subcutaneous implantation of DC-WJ showed total resorption after three weeks of implantation without any sign of foreign body reaction. These significant data shed light on the potential regenerative application of DC-WJ in providing a suitable biomaterial for tissue regenerative medicine and an ideal strategy to prevent wound-associated infections.
Keywords: Wharton’s jelly; antibacterial; bioactivity; decellularization; immunomodulation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures








Similar articles
-
Decellularization of Wharton's Jelly Increases Its Bioactivity and Antibacterial Properties.Front Bioeng Biotechnol. 2022 Mar 11;10:828424. doi: 10.3389/fbioe.2022.828424. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35360386 Free PMC article.
-
Human-derived extracellular matrix from Wharton's jelly: An untapped substrate to build up a standardized and homogeneous coating for vascular engineering.Acta Biomater. 2017 Jan 15;48:227-237. doi: 10.1016/j.actbio.2016.10.018. Epub 2016 Oct 18. Acta Biomater. 2017. PMID: 27769940
-
Wharton's Jelly Mesenchymal Stromal Cells from Human Umbilical Cord: a Close-up on Immunomodulatory Molecules Featured In Situ and In Vitro.Stem Cell Rev Rep. 2019 Dec;15(6):900-918. doi: 10.1007/s12015-019-09907-1. Stem Cell Rev Rep. 2019. PMID: 31741193
-
Mesenchymal Stem Cells from the Wharton's Jelly of the Human Umbilical Cord: Biological Properties and Therapeutic Potential.Int J Stem Cells. 2019 Jul 31;12(2):218-226. doi: 10.15283/ijsc18034. Int J Stem Cells. 2019. PMID: 31022994 Free PMC article. Review.
-
Human Wharton's Jelly-Cellular Specificity, Stemness Potency, Animal Models, and Current Application in Human Clinical Trials.J Clin Med. 2020 Apr 12;9(4):1102. doi: 10.3390/jcm9041102. J Clin Med. 2020. PMID: 32290584 Free PMC article. Review.
Cited by
-
Decellularized Umbilical Cord as a Scaffold to Support Healing of Full-Thickness Wounds.Biomimetics (Basel). 2024 Jul 3;9(7):405. doi: 10.3390/biomimetics9070405. Biomimetics (Basel). 2024. PMID: 39056846 Free PMC article.
-
Perspectives on the use of decellularized/devitalized and lyophilized human perinatal tissues for bone repair: Advantages and remaining challenges.Mater Today Bio. 2024 Nov 26;30:101364. doi: 10.1016/j.mtbio.2024.101364. eCollection 2025 Feb. Mater Today Bio. 2024. PMID: 39811604 Free PMC article.
-
Methods and criteria for validating the multimodal functions of perinatal derivatives when used in oncological and antimicrobial applications.Front Bioeng Biotechnol. 2022 Oct 13;10:958669. doi: 10.3389/fbioe.2022.958669. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36312547 Free PMC article. Review.
-
Tips and Tricks and Clinical Outcome of Cryopreserved Human Amniotic Membrane Application for the Management of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Pilot Study.Front Bioeng Biotechnol. 2022 Jul 22;10:936074. doi: 10.3389/fbioe.2022.936074. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35935507 Free PMC article.
-
Construction of 3D-Bioprinted cartilage-mimicking substitute based on photo-crosslinkable Wharton's jelly bioinks for full-thickness articular cartilage defect repair.Mater Today Bio. 2023 Jun 9;21:100695. doi: 10.1016/j.mtbio.2023.100695. eCollection 2023 Aug. Mater Today Bio. 2023. PMID: 37384040 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases